Literature DB >> 35648189

Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis.

Didem Erdem Gürsoy1, Halise Hande Gezer2, Sevtap Acer Kasman3, Mehmet Tuncay Duruöz4.   

Abstract

The study aimed to translate and cross-culturally adapt the self-comorbidity questionnaire (SCQ) into Turkish and investigate the validity and reliability of SCQ and its modified version (mSCQ) in psoriatic arthritis (PsA). Psoriatic arthritis quality of life (PsAQoL) and short form 36 (SF-36) were used to assess the quality of life. The physical disability was evaluated with the health assessment questionnaire (HAQ). The reliability of the SCQ scale was assessed by test-retest reliability. For construct validity, the correlations of SCQ with the HAQ, SF-36, PsAQoL, age, body mass index (BMI), disease duration, disease activity in psa (DAPSA), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Psoriasis Area and Severity Index (PASI), dactylitis and enthesitis were evaluated. The mSCQ was also used by removing the items related to rheumatic conditions. For the test-retest reliability of the Turkish version of SCQ, the intraclass correlation coefficient was 0.965, p < 0.001. The SCQ and mSCQ had significant correlations with HAQ, PsAQoL, some subscales of SF-36, and age (p < 0.05), but not with disease duration, BASDAI, PASI and dactylitis (p > 0.05). Although SCQ had a low correlation with DAPSA (rho = 0.262, p = 0.031), mSCQ was not correlated with DAPSA (p > 0.05). mSCQ was significantly correlated with BMI (rho = 0.233, p = 0.016), but SCQ was not (p > 0.05). The Turkish version of SCQ had adequate reliability and validity, and the mSCQ improved the validity of the scale in patients with PsA.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Comorbidity; Psoriatic arthritis; Psychometrics; Questionnaires

Mesh:

Substances:

Year:  2022        PMID: 35648189     DOI: 10.1007/s00296-022-05150-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  29 in total

1.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research.

Authors:  Oliver Sangha; Gerold Stucki; Matthew H Liang; Anne H Fossel; Jeffrey N Katz
Journal:  Arthritis Rheum       Date:  2003-04-15

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Reliability of a comorbidity measure: the Index of Co-Existent Disease (ICED).

Authors:  K Imamura; M McKinnon; R Middleton; N Black
Journal:  J Clin Epidemiol       Date:  1997-09       Impact factor: 6.437

Review 4.  Comorbidities associated with psoriatic arthritis: Review and update.

Authors:  Lourdes M Perez-Chada; Joseph F Merola
Journal:  Clin Immunol       Date:  2020-03-27       Impact factor: 3.969

Review 5.  The pathogenesis of psoriatic arthritis.

Authors:  Douglas J Veale; Ursula Fearon
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

6.  Patient-Reported Morbidity Instruments: A Systematic Review.

Authors:  Arvind Oemrawsingh; Nishwant Swami; José M Valderas; Jan A Hazelzet; Andrea L Pusic; Richard E Gliklich; Regan W Bergmark
Journal:  Value Health       Date:  2020-05-27       Impact factor: 5.725

Review 7.  The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review.

Authors:  Juan D Cañete; Jose Antonio Pinto Tasende; Francisco José Rebollo Laserna; Susana Gómez Castro; Rubén Queiro
Journal:  Rheumatol Ther       Date:  2020-04-08

8.  Comorbidities in psoriatic arthritis: a systematic review and meta-analysis.

Authors:  Sonal Gupta; Zoe Syrimi; David M Hughes; Sizheng Steven Zhao
Journal:  Rheumatol Int       Date:  2021-01-09       Impact factor: 2.631

9.  Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly?

Authors:  Adesuwa B Olomu; William D Corser; Manfred Stommel; Yan Xie; Margaret Holmes-Rovner
Journal:  BMC Health Serv Res       Date:  2012-11-14       Impact factor: 2.655

10.  Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study.

Authors:  Ennio Lubrano; Silvia Scriffignano; Ana Belen Azuaga; Julio Ramirez; Juan D Cañete; Fabio Massimo Perrotta
Journal:  Rheumatol Ther       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.